Skip to main content
Devi Nair

Devi Nair

Director of Cardiac Electrophysiology & Research at St. Bernard's Healthcare; expert in atrial fibrillation treatment and left atrial appendage occlusion

Jun 1, 2026

8:57
Can you tell us, um, after the OPTION trial, what was your initial reaction to the data, and how to actually see the results of, of the OPTION trial?
9:08
Well, um, you know, full disclosure, I was, I was an author in the OPTION trial, was one of the biggest enrollers in the OPTION trial.
9:14
And, um, my initial reaction was that OPTION validated what many of us have been wondering for many years.
9:22
You know, as, as electrophysiologists, we spend hours discussing rhythm control with our AF patients.
9:27
But when it comes to stroke prevention, we often default to lifelong anticoagulation because that's what guidelines said.
9:34
You know, you don't stop anticoagulation after an ablation.
9:37
You maintain stroke prevention based on their CHA2DS2-VASc score.

6 MINS LATER

15:46
What do you think about that?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.